Cargando…
A sphingosine‐1‐phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration
BACKGROUND AND PURPOSE: Intracranial aneurysm (IA), common in the general public, causes lethal subarachnoid haemorrhage on rupture. It is, therefore, of utmost importance to prevent the IA from rupturing. However, there is currently no medical treatment. Recent studies suggest that IA is the result...
Autores principales: | Yamamoto, Rie, Aoki, Tomohiro, Koseki, Hirokazu, Fukuda, Miyuki, Hirose, Jun, Tsuji, Keiichi, Takizawa, Katsumi, Nakamura, Shinichiro, Miyata, Haruka, Hamakawa, Nozomu, Kasuya, Hidetoshi, Nozaki, Kazuhiko, Hirayama, Yoshitaka, Aramori, Ichiro, Narumiya, Shuh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466536/ https://www.ncbi.nlm.nih.gov/pubmed/28409823 http://dx.doi.org/10.1111/bph.13820 |
Ejemplares similares
-
T cell function is dispensable for intracranial aneurysm formation and progression
por: Miyata, Haruka, et al.
Publicado: (2017) -
ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile
por: Yamamoto, Rie, et al.
Publicado: (2014) -
RNA sequencing analysis revealed the induction of CCL3 expression in human intracranial aneurysms
por: Aoki, Tomohiro, et al.
Publicado: (2019) -
Real-time Imaging of an Experimental Intracranial Aneurysm in Rats
por: MIYATA, Haruka, et al.
Publicado: (2019) -
4058 Enhanced efficiency of large-scale clinical proteomic studies: when less is more
por: Thomas, Stefani, et al.
Publicado: (2020)